Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-752-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Not skin irritant
Not eye irritant
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
No information on "irritation/corrosion" of the Target Substance is available. However data on a similar substance (Similar Substance 01) has been taken into account for the assessment. More details on the substance similarity are reported in section 13.
Skin Irritation/Corrosion
Key study
A skin irritation study in three New Zealand White rabbits (2 males, 1 female) was performed according to OECD guideline 404 and EU Method B.4. Therefore, 0.5 g of the test substance (60 % act. ingr.) was applied to approx. 6 square cm of the intact skin of the clipped area and covered in a semi-occlusive manner for 4 hours. The skin reaction was assessed at 1, 24, 48 and 72 hours after the removal of the test substance. Local signs (mean values from 24, 48, 72 hours) consisted of grade 0.0 erythema and grade 0.0 edema. No acute clinical symptoms were observed in the animals during the test and observation period, and no mortality occurred. In the area of application a red staining of the treated skin by pigment or coloring of the test article was observed.
Supporting study
An acute dermal irritation study was performed in accordance to OECD guideline No. 404 and Method B4 in Commission Directive 92/69/EEC to determine the irritancy potential of the test material (49 % act. ingr.) to the skin of three New Zealand White rabbits (2 females, 1 male). The rabbits were clipped free of fur from the dorsal flank area using veterinary clippers 24 hours before treatment. On the day of the test, a quantity of 0.5g of the test material, moistened with 0.5 mL of distilled water, was introduced under a 2.5 cm x 2.5 cm cottongauze patch and placed in position on the shorn skin. The patch was secured in position with a strip of surgical adhesive tape (BLENDERM: approximate size 2.5 cm x 4.0 cm). To prevent the animals interfering with the patches, the trunk of each rabbit was wrapped in an elasticated corset (TUBIGRIP) and the animals were returned to their cages for the duration of the exposure period. Four hours after application the corset and patches were removed from each animal and any residual test material removed by gentle swabbing with cotton wool soaked in 74% Industrial Methylated Spirits. Approximately one hour following the removal of the patches, and 24, 48 and 72 hours later, the test sites were examined for evidence of primary irritation and scored according to the following scale from Draize. Pink staining of the treatment site was noted in one animal at the 1, 24, 48 and 72-hour observations. Very slight erythema was noted at all treatment sites at the 1-hour observation and two treatment sites at the 24, 48 and 72-hour observations. Desquamation was noted at two treatment sites at the 7-day observation. An isolated incident of very slight oedema was noted at one treatment site at the 24-hour observation.
Both the key and supporting study indicated that the test material was not irritating to the rabbits' skin.
Eye Irritation/Corrosion
Key study
An eye irritation study in three New Zealand rabbits (1 male, 2 females) was performed according to OECD guideline 405 and EU Method B.5. 0.1 g of the test substance (60 % act. integr.) was placed in the left eye of each animal and the lids were gently held together for about one second. The eyes of each animal were exmamined for ocula irritation 1, 24, 48, 72 hours, 7, 14 and 21 days after administration.
No necropsy was performed in the animals euthanized at termination of observation. No acute clinical symptoms were observed in the animals during the test and observation period, and no mortality occured. The body weight gain of all rabbits was similar. The mean scores (over time points 24 h, 48 h, 72 h) for animal 1 were determined to be 0.0 for cornea, 0.0 for iris, 1.0 for conjunctivae redness and 0.0 for chemosis. For animal 2, the mean scores were 0.33 for cornea, 0.0 for iris, 1.0 for conjunctiva redness and 0.33 for chemosis. For animal 3, the mean scores were 0.0 for cornea, 0.0 for iris, 1.0 for conjunctiva redness and 1.0 for chemosis. The observed effects were fully reversible within the 21 -day observation period.
Supporting study
An acute eye irritation study was performed in accordance to OECD guideline No. 405 and Method B5 in Commission Directive 92/69/EECto determine the irritancy potential of the test material (49 % act. integr.) to the eyes of three New Zealnd White rabbits (2 females, 1 male). A volume of 0.1 mL of the test material, which was found to weigh approximately 98 mg was placed into the conjunctival sac of the right eye, formed by gently pulling the lower lid away from the eyeball. The upper and lower eyelids were held together for about one second immediately after application, to prevent loss of the test material, and then released. The left eye remained untreated and was used for control purposes.In order to minimise pain on instillation of the test material, one drop of local anaesthetic ("Ophthaine", 0.5% proxymetacaine hydrochloride, E.R. Squibb & Sons Limited, Hounslow, Middlesex, U.K.) was instilled into both eyes of these animals 1 - 2 minutes before treatment. Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment in accordance to the OECD scoring system. Examination of the eye was facilitated by use of the light source from a standard ophthalmoscope. Additional observations were made on days seven, fourteen and twenty-one to assess the reversibility of the ocular effects. Residual test material was noted in all treated eyes throughout the study period. The mean scores (over time points 24 h, 48 h, 72 h) for animal 1 were determined to be 0 for cornea, 0 - 1.3 for iris, 0.7 - 1.7 for conjunctivae redness and 1.3 for chemosis. Dark pink/purple-coloured staining prevented accurate evaluation of iridial inflammation in the treated eye of animal 2 at the 24 and 48 -hour observations. For animal 2, the mean scores were 0 for cornea, 0 for iris, 1 for conjunctiva redness and 0.7 for chemosis. For animal 3, the mean scores were 1.0 for cornea, 0.3 for iris, 1.7 for conjunctiva redness and 1.3 for chemosis. Likewise, vascularisation in animal 3 was observed at the 7 and 14 -day obervations. The observed irritation paramters were fully reversible within the observation period.
On the basis of the key and supporting study, the test material is considered to be non-irritating to the rabbits' eye.
Justification for selection of skin irritation / corrosion endpoint:
OECD guideline study; test material with highest concentration of active ingredient
Justification for selection of eye irritation endpoint:
OECD guideline study; test material with highest concentration of active ingredient
Justification for classification or non-classification
SKIN IRRITATION/CORROSION
A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to 4 hour duration.
Three subcategories are provided within the corrosive category 1:
Subcategory 1A where responses are noted following up to 3 minutes exposure and up to 1 hour observation;
Subcategory 1B where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days;
Subcategory 1C where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days
To classify a substance as irritant, the major criterion is that at least 2 of 3 tested animals have a mean score of ≥ 2,3 - ≤ 4,0.
Category 2:
- Mean value of ≥ 2,3 - ≤ 4,0 for erythema/ eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or
- Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or
- In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical eposure in a single animal but less than the criteria above.
EYE IRRITATION
Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application.
Eye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.
Irreversible effects on the eye (Category 1):
If, when applied to the eye of an animal, a substance produces:
- at least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/ or
- at least in 2 of 3 tested animals, a positive response of corneal opacity ≥ 3 and/or iritis > 1,5 calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material.
These observations include animals with grade 4 cornea lesions and other severe reactions (e.g., destruction of cornea) observed at any time during the test, as well as persistent corneal opacity, discoloration of the cornea by a dye substance, adhesion, pannus, and interference with the function of the iris or other effects that impair sight. In this context, persistent lesions are considered those which are not fully reversible within an observation period of normally 21 days. Substances are also classified in Category 1 if they fulfil the criteria of corneal opacity ≥ 3 or iritis > 1,5 detected in a Draize eye test with rabbits, recognising that such severe lesions usually do not reverse within a 21-day observation period.
The substance does not meet the requirements to be classified in Category 1.
Irritating to eyes (Category 2)
when applied to the eye of an animal, a substance produces:
- at least in 2 of 3 tested animals, a positive response of: corneal opacity ≥ 1 and/or iritis ≥ 1, and/or conjunctival redness ≥ 2 and/or conjunctival oedema (chemosis) ≥ 2
calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days.
Based on the results obtained in the skin and eye irritation studies, the test substance does not need to be classified for skin and eye irritation according to the CLP Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.